Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS

Overview of attention for article published in BMC Cancer, February 2014

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 63 Dimensions

Readers on

mendeley: 66 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

INDOLE COMPOUNDS AS EZH2 INHIBITORS AND USES THEREOF

Application EP-3885343-A1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.